The Del E. Webb Center for Neuroscience and Aging was established at The Burnham Institute
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
UCSF Cancer Research Institute received NCI Comprehensive Cancer Center designation
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Livermore National Lab work was completed on the mouse genome as part of Laboratory efforts in comparative genomics
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
Louis J. Ignarro was awarded Nobel Prize in Physiology or Medicine
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
Walter Kohn was awarded Nobel Prize in Chemistry
O Oct. 13, 1998, Walter Kohn of the University of California at Santa Barbara was awarded the 1998…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Monoclonal antibody rituximab (Rituxan) approved by the FDA to treat patients with non-Hodgkin lymphoma
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
Stanford researchers performed first optical imaging of gene expression in vivo
On Oct. 9, 1997, Stanford researchers announced that in a series of experiments performed in mice and rats,…
The UCI Chao Family Comprehensive Cancer Center gained comprehensive cancer center status
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
Alfred Mann gave $112.5 million to establish the USC Alfred E Mann Institute for Biomedical Engineering
In 1998, Alfred Mann gave $112.5 million to establish the University of Southern California Alfred E. Mann Institute…
Paul D Boyer awarded Nobel Prize in Chemistry
In 1997, Paul D. Boyer of the University of California at Los Angeles was awarded the Nobel Prize…
The National Fibromyalgia Association was founded in Orange, California
In 1997, the National Fibromyalgia Association (NFA), the largest nonprofit [501(c)3] organization working to support people with fibromyalgia…
Stanford researchers discovered that the p53 protein works as an ’emergency brake’ on cancer development
On Jan. 2, 1996, Stanford Medicine researchers announced they had discovered that the p53 protein, known to be…
Livermore National Lab delivered the first fully portable, battery-powered, real-time DNA analysis system to the US Army
In 1996, Livermore National Lab delivered to the U.S. Army for testing the first fully portable, battery-powered, real-time…
Stanford researchers discovered that mutations in a single gene are responsible for most common form of skin cancer
In 1996, Stanford Medicine developmental biologist Matthew Scott and a team at University of California, San Francisco discovered…
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Therapeutics
GeneChip was developed by Stanford University and Affymetrix
On Dec. 11, 1996, scientists from Stanford University and Affymetrix announced a new high-tech method that used a…
Biology | Chemistry | Diagnostics | Disease | Therapeutics
The Skaggs Institute for Chemical Biology was established at The Scripps Research Institute
In 1996, the Skaggs Institute for Chemical Biology was established at The Scripps Research Institute, thanks to a…
The National Cervical Cancer Coalition, a growing coalition of people battling cervical cancer and related issues, was founded in California
In 1996, the National Cervical Cancer Coalition (NCCC), a growing coalition of people battling cervical cancer and HPV…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved
On Dec. 29, 1995, the Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved by the…
Genentech drug CellCept (mycophenolate mofetil) approved by FDA
On May 3, 1995, the U.S. Food & Drug Administration (FDA) announced it had approved Genentech’s drug CellCept…
The first department of bioengineering in the U.S. was established at UC San Diego
In 1995, the first department of bioengineering in the U.S. was established at the University of California, San…
Southern California Biomedical Council was founded
In 1995, Southern California Biomedical Council (SCBC), was founded with support from Rebuild LA (RLA) under its second…
The UCI Chao Family Cancer Center bacame a NCI-designated cancer center
On Oct. 26, 1994, the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained designated…
The FDA approved the first genetically modified food: the “Flavr Savr” tomato
On May 17, 1994, the U.S. Food and Drug Administration (FDA) approved of the first genetically modified food:…
Amgen acquired Boulder-based Synergen facility
In 1994, Amgen announced it had acquired Boulder-based Synergen for a $239.6-million or $9.25 per share. Synergen was…
CyberKnife was developed at Stanford University
In 1994, CyberKnife developed by John Adler, MD and colleagues at Stanford University. CyberKnife’s special quality is that…